147 related articles for article (PubMed ID: 11368062)
1. Acquired and inherited risk factors for splanchnic venous thrombosis.
De Stefano V; Teofili L; Leone G
Blood; 2001 May; 97(10):3314-5. PubMed ID: 11368062
[No Abstract] [Full Text] [Related]
2. JAK2 V617F Mutation Testing in Patients Presenting With Hepatic and Portal Vein Thrombosis.
Foucar CE; Stein BL
JAMA; 2017 Jun; 317(21):2228-2229. PubMed ID: 28586872
[No Abstract] [Full Text] [Related]
3. The role of thrombophilia in splanchnic vein thrombosis.
Primignani M; Mannucci PM
Semin Liver Dis; 2008 Aug; 28(3):293-301. PubMed ID: 18814082
[TBL] [Abstract][Full Text] [Related]
4. [Budd-Chiari syndrome and splanchnic vein thrombosis: masked myeloproliferative neoplasms and JAK2V617F].
Fama A; Rago A; Gioiosa F; Marzano C; Latagliata R; Mammì C; Laganà C; D'Elia GM; Bizzoni L; Trasarti S; Ferretti A; Breccia M; Riggio O; Tafuri A
Clin Ter; 2010; 161(2):169-71. PubMed ID: 20499034
[TBL] [Abstract][Full Text] [Related]
5. [Myeloproliferative diseases as causative agents of portal and hepatic veins thrombosis].
Culafić Dj; Miljić P; Perisić M; Djuranović S; Popović D; Krstić M; Jovanović I; Pavlović A; Mijalković N; Sokić-Milutinović A; Pesko P
Acta Chir Iugosl; 2007; 54(1):83-9. PubMed ID: 17633867
[TBL] [Abstract][Full Text] [Related]
6. Prothrombotic disorders in abdominal vein thrombosis.
Leebeek FW; Smalberg JH; Janssen HL
Neth J Med; 2012 Nov; 70(9):400-5. PubMed ID: 23123534
[TBL] [Abstract][Full Text] [Related]
7. JAK2 mutation: The best diagnostic tool for myeloproliferative disease in splanchnic vein thrombosis?
Janssen HL; Leebeek FW
Hepatology; 2006 Dec; 44(6):1391-3. PubMed ID: 17133464
[No Abstract] [Full Text] [Related]
8. Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases.
Lavu S; Szuber N; Mudireddy M; Yogarajah M; Gangat N; Pardanani A; Hanson CA; Ketterling RP; Ashrani AA; Kamath PS; Tefferi A
Am J Hematol; 2018 Mar; 93(3):E61-E64. PubMed ID: 29194707
[No Abstract] [Full Text] [Related]
9. Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis: similarities and differences.
Smalberg JH; Kruip MJ; Janssen HL; Rijken DC; Leebeek FW; de Maat MP
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):485-93. PubMed ID: 21325670
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis.
De Stefano V; Teofili L; Leone G; Michiels JJ
Semin Thromb Hemost; 1997; 23(5):411-8. PubMed ID: 9387199
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of the JAK2 V617F mutation associated with splanchnic vein thrombosis. A 10-year retrospective study.
Tondeur S; Boutruche S; Biron-Andréani C; Schved JF
Thromb Haemost; 2009 Apr; 101(4):787-9. PubMed ID: 19350131
[No Abstract] [Full Text] [Related]
12. Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.
Smalberg JH; Arends LR; Valla DC; Kiladjian JJ; Janssen HL; Leebeek FW
Blood; 2012 Dec; 120(25):4921-8. PubMed ID: 23043069
[TBL] [Abstract][Full Text] [Related]
13. JAK2V617F mutation in patients with splanchnic vein thrombosis.
Xavier SG; Gadelha T; Pimenta G; Eugenio AM; Ribeiro DD; Gomes FM; Bonamino M; Zalcberg IR; Spector N
Dig Dis Sci; 2010 Jun; 55(6):1770-7. PubMed ID: 19690956
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis.
Karaköse S; Oruç N; Zengin M; Akarca US; Ersöz G
Turk J Gastroenterol; 2015 Jan; 26(1):42-8. PubMed ID: 25698270
[TBL] [Abstract][Full Text] [Related]
15. Acute partial Budd-Chiari syndrome and portal vein thrombosis in cytomegalovirus primary infection: a case report.
Spahr L; Cerny A; Morard I; Rubbia-Brandt L; Schrenzel J
BMC Gastroenterol; 2006 Mar; 6():10. PubMed ID: 16529659
[TBL] [Abstract][Full Text] [Related]
16. Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms.
Fiorini A; Chiusolo P; Rossi E; Za T; De Ritis DG; Ciminello A; Leone G; De Stefano V
Am J Hematol; 2009 Feb; 84(2):126-7. PubMed ID: 19105231
[No Abstract] [Full Text] [Related]
17. Hepatic and portal vein-thrombosis.
Boughton BJ
BMJ; 1991 Jan; 302(6770):192-3. PubMed ID: 1998755
[No Abstract] [Full Text] [Related]
18. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors.
Denninger MH; Chaït Y; Casadevall N; Hillaire S; Guillin MC; Bezeaud A; Erlinger S; Briere J; Valla D
Hepatology; 2000 Mar; 31(3):587-91. PubMed ID: 10706547
[TBL] [Abstract][Full Text] [Related]
19. Budd-Chiari syndrome and portal vein thrombosis associated with myeloproliferative disorders: diagnosis and management.
Brière JB
Semin Thromb Hemost; 2006 Apr; 32(3):208-18. PubMed ID: 16673275
[TBL] [Abstract][Full Text] [Related]
20. Portal vein thrombosis and budd-Chiari syndrome.
Bittencourt PL; Couto CA; Ribeiro DD
Clin Liver Dis; 2009 Feb; 13(1):127-144. PubMed ID: 19150317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
